82 FR 26929 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 111 (June 12, 2017)

Page Range		26929-26930
FR Document		2017-12124

Federal Register, Volume 82 Issue 111 (Monday, June 12, 2017)

[Federal Register Volume 82, Number 111 (Monday, June 12, 2017)]
[Notices]
[Pages 26929-26930]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-12124]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of a 
single-source supplement for Funding Opportunity Announcement (FOA) 
CK16-003, Pre-travel Health Preparation of International Travelers: 
Expanding and Improving Data Collection, Guidance, and Outreach.
    Time and Date: 12:00 p.m.-2:00 p.m., EDT, July 18, 2017 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion and evaluation of a single-source supplement 
application for ``Pre-travel Health Preparation of

[[Page 26930]]

International Travelers: Expanding and Improving Data Collection, 
Guidance, and Outreach'', CK16-003.
    Contact Person for More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop 
E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-12124 Filed 6-9-17; 8:45 am]
 BILLING CODE 4163-18-P

Federal Register / Vol. 82, No. 111 / Monday, June 12, 2017 / Notices 26929

Control No. 0923–0054, expiration date During Activity 1, ATSDR and US with crumb rubber infill. This
01/31/2017). The research goals for the EPA obtained permission to return to instrument, along with extant
three activities in the protocol are pilot- some of the participating fields to videography of persons engaged in
level investigations to evaluate and complete the human exposure activities of interest (see below), will be
characterize: The chemical composition characterization. Due to the limited time used to characterize exposure scenarios,
and use of crumb rubber infill in constraints and field activity schedules, including the nature and duration of
synthetic turf using a convenience ATSDR and US EPA chose to begin potential exposures.
sample of nine tire recycling Activity 2 data collection and Activity
manufacturing plants and 40 facilities 3 specimen collection in 2017. The research study will screen a total
that use synthetic turf fields (Activity 1); The agencies are submitting a new of 75 participants for eligibility. The
The human exposure potential to information collection request (ICR) for sample size for the Activity 2 exposure
constituents in crumb rubber infill a one-year PRA clearance to complete characterization is 60 respondents. For
among a convenience sample of 60 field Activity 2 and Activity 3, now subtitled Activity 3, we will conduct an exposure
users (Activity 2); and collection of ‘‘Characterization of Exposure Potential measurements sub-study among 45 of
biological specimens (blood and urine) during Activities Conducted on the 60 respondents, including field
from 45 participants from Activity 2 Synthetic Turf with Crumb Rubber environmental sampling, personal air
(Activity 3). Infill.’’ This will be the first assessment monitoring, dermal sampling, and urine
By December, 2016, ATSDR and US of activities conducted on synthetic turf and blood collection. Video data
EPA completed Activity 1 which was for the purpose of characterizing collection of facility user activities will
aimed at characterizing the chemical potential exposure patterns. The study be performed for a further subset of 24
composition and use of synthetic turf will include persons who use synthetic of the Activity 2 respondents. It is likely
fields with tire crumb rubber infill. The turf with crumb rubber infill (e.g., that some of the collection items will
agencies successfully consented and facility users) and who routinely not be analyzed in the current project
sampled 40 synthetic turf fields with perform activities that would result in a
time frame but will be archived for
crumb rubber infill across the United high level of contact to crumb rubber.
future analysis.
States. The activities are reported in the This will allow for the evaluation of
‘‘Status Report on the Federal Research potential high-end exposures to The total estimated annual time
Action Plan on Recycled Tire Crumb constituents in synthetic turf among this burden requested for this research
Used on Playing Fields and group of users. The respondents will be activity equals 174 hours. There is no
Playgrounds,’’ which was released on administered a detailed questionnaire cost to the respondents other than their
December 30, 2016. on activity patterns on synthetic turf time in the study.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per
Type of respondents Form name responses per
respondents response
respondent (in hours)

Adult/Adolescent Facility Users ...................... Eligibility Screening Script .............................. 41 1 5/60
Adult and Adolescent Questionnaire ............. 36 1 30/60
Exposure Measurement Form ....................... 27 1 3
Phlebotomist Safety Exclusion Questions 27 1 2/60
Form.
Parents/Guardians of Youth/Child Facility Eligibility Screening Script .............................. 34 1 5/60
Users.
Youth and Child Questionnaire ...................... 24 1 30/60
Phlebotomist Safety Exclusion Questions 18 1 2/60
Form.
Youth/Child Facility Users ............................... Exposure Measurement Form ....................... 18 1 3

Leroy A. Richardson, DEPARTMENT OF HEALTH AND Expanding and Improving Data
Chief, Information Collection Review Office, HUMAN SERVICES Collection, Guidance, and Outreach.
Office of Scientific Integrity, Office of the Time and Date: 12:00 p.m.–2:00 p.m.,
Associate Director for Science, Office of the Centers for Disease Control and EDT, July 18, 2017 (Closed).
Director, Centers for Disease Control and Prevention Place: Teleconference.
Prevention.
Disease, Disability, and Injury Status: The meeting will be closed to
[FR Doc. 2017–12061 Filed 6–9–17; 8:45 am]
Prevention and Control Special the public in accordance with
BILLING CODE 4163–18–P
Emphasis Panel (SEP): Initial Review provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
determination of the Director,
asabaliauskas on DSKBBXCHB2PROD with NOTICES

In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act Management Analysis and Services
(Pub. L. 92–463), the Centers for Disease Office, CDC, pursuant to Public Law 92–
Control and Prevention (CDC) 463.
announces a meeting for the initial Matters for Discussion: The meeting
review of a single-source supplement for will include the initial review,
Funding Opportunity Announcement discussion and evaluation of a single-
(FOA) CK16–003, Pre-travel Health source supplement application for ‘‘Pre-
Preparation of International Travelers: travel Health Preparation of

VerDate Sep<11>2014 17:28 Jun 09, 2017 Jkt 241001 PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 E:\FR\FM\12JNN1.SGM 12JNN1

26930 Federal Register / Vol. 82, No. 111 / Monday, June 12, 2017 / Notices

International Travelers: Expanding and Prevention and the Agency for Toxic should be received within 30 days of
Improving Data Collection, Guidance, Substances and Disease Registry. this notice.
and Outreach’’, CK16–003. Elaine L. Baker, Proposed Project
Contact Person for More Information: Director, Management Analysis and Services ZEN Colombia Study: Zika in
Gregory Anderson, M.S., M.P.H., Office, Centers for Disease Control and Pregnant Women and Children in
Scientific Review Officer, CDC, 1600 Prevention. Colombia—New—Pregnancy and Birth
Clifton Road NE., Mailstop E60, Atlanta, [FR Doc. 2017–12125 Filed 6–9–17; 8:45 am] Defects Task Force, National Center on
Georgia 30333, Telephone: (404) 718– BILLING CODE 4163–18–P Birth Defects and Developmental
8833. Disabilities, Centers for Disease Control
The Director, Management Analysis and Prevention (CDC).
DEPARTMENT OF HEALTH AND
and Services Office, has been delegated Background and Brief Description
HUMAN SERVICES
the authority to sign Federal Register
Zika virus (ZIKV) infection is a
notices pertaining to announcements of Centers for Disease Control and mosquito-borne flavivirus transmitted
meetings and other committee Prevention by Aedes species mosquitoes, and also
management activities, for both the through sexual and mother-to-child
Centers for Disease Control and [30Day–17–17ABB]
transmission; laboratory-acquired
Prevention and the Agency for Toxic infections have also been reported.
Agency Forms Undergoing Paperwork
Substances and Disease Registry. Reduction Act Review Evidence of human ZIKV infection was
Elaine L. Baker, observed sporadically in Africa and
The Centers for Disease Control and Asia prior to 2007, when an outbreak of
Director, Management Analysis and Services Prevention (CDC) has submitted the
Office, Centers for Disease Control and
ZIKV caused an estimated 5,000
following information collection request infections in the State of Yap, Federated
Prevention.
to the Office of Management and Budget States of Micronesia. Since then,
[FR Doc. 2017–12124 Filed 6–9–17; 8:45 am] (OMB) for review and approval in evidence of ZIKV has been found in 65
BILLING CODE 4163–18–P accordance with the Paperwork countries and territories, mostly in
Reduction Act of 1995. The notice for Central and South America. Common
the proposed information collection is symptoms of ZIKV in humans include
DEPARTMENT OF HEALTH AND published to obtain comments from the rash, fever, arthralgia, and nonpurulent
HUMAN SERVICES public and affected agencies. conjunctivitis. The illness is usually
Written comments and suggestions mild and self-limited, with symptoms
Centers for Disease Control and from the public and affected agencies lasting for several days to a week;
Prevention concerning the proposed collection of however, based on previous outbreaks,
information are encouraged. Your some infections are asymptomatic. The
World Trade Center Health Program comments should address any of the prevalence of asymptomatic infection in
Scientific/Technical Advisory following: (a) Evaluate whether the the current Central and South American
Committee: Notice of Charter Renewal proposed collection of information is epidemic is unknown.
necessary for the proper performance of Although the clinical presentation of
This gives notice under Public Law the functions of the agency, including ZIKV infection is typically mild, ZIKV
111–347 (The James Zadroga 9/11 whether the information will have infection in pregnancy can cause
Health and Compensation Act of 2010) practical utility; (b) Evaluate the microcephaly and related brain
and the Federal Advisory Committee accuracy of the agencies estimate of the abnormalities when fetuses are exposed
Act (Pub. L. 92–463) of October 6, 1972, burden of the proposed collection of in utero. Other adverse pregnancy
that the World Trade Center Health information, including the validity of outcomes related to ZIKV infection
Program Scientific/Technical Advisory the methodology and assumptions used; remain under study, and include
Committee, Centers for Disease Control (c) Enhance the quality, utility, and pregnancy loss, other major birth
and Prevention, Department of Health clarity of the information to be defects, arthrogryposis, eye
and Human Services, has been renewed collected; (d) Minimize the burden of abnormalities, and neurologic
for a 2-year period through May 12, the collection of information on those abnormalities.
2019. who are to respond, including through As the spectrum of adverse health
For information, contact Paul J. the use of appropriate automated, outcomes potentially related to ZIKV
Middendorf, Ph.D., Designated Federal electronic, mechanical, or other infection continues to grow, large gaps
Officer, National Institute for technological collection techniques or remain in our understanding of ZIKV
Occupational Safety and Health, Centers other forms of information technology, infection in pregnancy. These include
for Disease Control and Prevention, e.g., permitting electronic submission of the full spectrum of adverse health
Department of Health and Human responses; and (e) Assess information outcomes in pregnant women, fetuses,
Services, 2400 Century Parkway NE., collection costs. and infants associated with ZIKV
Mail Stop E–20, Atlanta, Georgia 30345, To request additional information on infection; the relative contributions of
the proposed project or to obtain a copy sexual transmission and mosquito-borne
telephone 1 (888) 982–4748; email: wtc-
asabaliauskas on DSKBBXCHB2PROD with NOTICES

of the information collection plan and transmission to occurrence of infections
stac@cdc.gov.
instruments, call (404) 639–7570 or in pregnancy; and variability in the risk
The Director, Management Analysis send an email to omb@cdc.gov. Direct of adverse fetal outcomes by gestational
and Services Office, has been delegated written comments and/or suggestions week of maternal infection or symptoms
the authority to sign Federal Register regarding the items contained in this of infection. There is an urgency to fill
notices pertaining to announcements of notice to the Attention: CDC Desk these large gaps in our understanding
meetings and other committee Officer, Office of Management and given the rapidity of the epidemic’s
management activities for both the Budget, Washington, DC 20503 or by fax spread and the severe health outcomes
Centers for Disease Control and to (202) 395–5806. Written comments associated with ZIKV to date.

VerDate Sep<11>2014 17:28 Jun 09, 2017 Jkt 241001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\12JNN1.SGM 12JNN1

Document Created: 2017-06-10 01:40:33
Document Modified: 2017-06-10 01:40:33

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		12:00 p.m.-2:00 p.m., EDT, July 18, 2017 (Closed).
FR Citation		82 FR 26929

82 FR 26929 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 82, Issue 111 (June 12, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention